APOA4 Antikörper (C-Term)
-
- Target Alle APOA4 Antikörper anzeigen
- APOA4 (Apolipoprotein A-IV (APOA4))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOA4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- RQKLGPHAGD VEGHLSFLEK DLRDKVNSFF STFKEKESQD KTLSLPELEQ
- Homologie
- Human: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against APOA4. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human APOA4
- Top Product
- Discover our top product APOA4 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 396 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background." in: BMC bioinformatics, Vol. 9, pp. 254, (2008) (PubMed).
: "
-
New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background." in: BMC bioinformatics, Vol. 9, pp. 254, (2008) (PubMed).
-
- Target
- APOA4 (Apolipoprotein A-IV (APOA4))
- Andere Bezeichnung
- APOA4 (APOA4 Produkte)
- Synonyme
- Apo-AIV antikoerper, ApoA-IV antikoerper, apoAIV antikoerper, APOAIV antikoerper, APOA4 antikoerper, myh11 antikoerper, Apoa-4 antikoerper, apolipoprotein A4 antikoerper, apolipoprotein A4 L homeolog antikoerper, apolipoprotein A-IV antikoerper, apolipoprotein A-IV a antikoerper, APOA4 antikoerper, Apoa4 antikoerper, apoa4 antikoerper, apoa4.L antikoerper, apoa4a antikoerper
- Hintergrund
-
The gene encoding APOA4 protein contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: MGC142154, MGC142156
Protein Interaction Partner: ALB, GPLD1, APOA4,
Protein Size: 396 - Molekulargewicht
- 43 kDa
- Gen-ID
- 337
- NCBI Accession
- NM_000482, NP_000473
- UniProt
- P06727
- Pathways
- Lipid Metabolism
-